Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
23,443,247
-
Share change
-
+2,974,112
-
Total reported value
-
$2,282,497,533
-
Put/Call ratio
-
102%
-
Price per share
-
$97.39
-
Number of holders
-
262
-
Value change
-
+$253,768,383
-
Number of buys
-
131
-
Number of sells
-
134
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q4 2018
As of 31 Dec 2018,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
262 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,443,247 shares.
The largest 10 holders included
Capital Research Global Investors, Capital World Investors, SCOPIA CAPITAL MANAGEMENT LP, PRUDENTIAL PLC, CANADA PENSION PLAN INVESTMENT BOARD, FRED ALGER MANAGEMENT INC, BARCLAYS PLC, Rock Springs Capital Management LP, JANUS HENDERSON GROUP PLC, and MORGAN STANLEY.
This page lists
262
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.